Creotech Instruments (CRI) Q1 2026 earnings summary

Executive summary

• Revenue from continuing operations for Q1 2026 was 16.8m PLN, down 4.9m PLN year-over-year, mainly due to project schedules, not a reduction in business scale.

• Operating costs rose by 9.7m PLN to 28.4m PLN, driven by higher employment, a stock option program, and increased subcontractor costs.

• Net loss from continuing operations was -8.4m PLN versus a profit of 2.7m PLN a year earlier.

• The quantum systems segment was spun off into Creotech Quantum S.A., presented as discontinued operations.

Financial highlights

• Total revenue: 22.4m PLN (flat year-over-year).

• Revenue from continuing operations: 16.8m PLN (down from 21.7m PLN).

• Operating loss: -10.5m PLN (vs. profit of 3.0m PLN year-over-year).

• Net loss: -6.9m PLN (vs. profit of 1.4m PLN year-over-year).

• Cash flow from operations: -36.4m PLN (vs. +13.0m PLN year-over-year).

• Cash and equivalents at period end: 83.9m PLN.

Outlook and guidance

• Results for future quarters will depend on milestone recognition in large projects, especially Mikroglob, and the timing of contract execution.

• The company launched a public offering of up to 650,000 new shares to raise approx. 100m EUR for its 2026-2029 strategy.

• Success in securing ESA contracts and timely execution by subcontractors will impact future results.